Research Publications on "Sho-saiko-to" (1990-2001)

 

2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990

Is your "Sho-saiko-to" manufactured under the same quality standard as the ones approved by the Japanese Ministry of Health, Welfare, and Labor? Find out more...

<18>

Authors

  Yamashiki M.  Nishimura A.  Nobori T.  Nakabayashi S.  Takagi T.  Inoue K.

  Ito M.  Matsushita K.  Ohtaki H.  Kosaka Y.

Institution

  Department of Laboratory Medicine, Mie University School of Medicine, Tsu,

  Japan.

Title

  In vitro effects of sho-saiko-to on production of

  granulocyte colony-stimulating factor by mononuclear cells from patients with

  chronic hepatitis C.

Source

  International Journal of Immunopharmacology.  19(7):381-5, 1997 Jul.

Abstract

  During the past 2 years, drug-induced interstitial pneumonia was reported in

  66 Japanese patients, mainly among chronic hepatitis C patients, undergoing

  treatment with the Japanese herbal medicine "Sho-saiko-to"

  (TJ-9). As interstitial pneumonia is also induced by granulocyte

  colony-stimulating factor (G-CSF), we examined the effects of TJ-9 on G-CSF

  production in peripheral blood mononuclear cells. In patients with hepatitis

  B or C, G-CSF production in the absence of any stimulation was significantly

  lower than healthy controls (p < 0.01). G-CSF production increased along with

  the increase of TJ-9 levels, and this could induce excessive production of

  G-CSF in hepatitis C patients, and this may be a cause of interstitial

  pneumonia.

 

<19>

Authors

  Ohta Y.  Nishida K.  Sasaki E.  Kongo M.  Hayashi T.  Nagata M.  Ishiguro I.

Institution

  Department of Biochemistry, School of Medicine, Fujita Health University,

  Aichi, Japan.

Title

  Comparative study of oral and parenteral administration of

  sho-saiko-to (xiao-chaihu-tang) extract on

  D-galactosamine-induced liver injury in rats.

Source

  American Journal of Chinese Medicine.  25(3-4):333-42, 1997.

Abstract

  The preventive effect of Sho-saiko-to (Xiao-Chaihu-Tang)

  extract (TJ-9) on the progression of D-galactosamine (GaIN)-induced liver

  injury was examined in five week-old male Wistar rats with oral (p.o.) or

  intraperitoneal (i.p.) administration of the same dose of TJ-9. Rats treated

  once with GaIN (500 mg/kg body weight, i.p.) received TJ-9 at a dose of 1.0

  g/kg body weight (p.o. or i.p.) 2 hours after GaIN treatment at which time an

  apparent liver injury occurred. Both p.o. and i.p. administration of TJ-9

  showed similar significant prevention against the progression of liver injury

  24 hours after GaIN injection. Although total protein and albumin

  concentrations in serum and protein concentration in the liver decreased with

  the progression of GaIN-induced liver injury, oral or i.p. administration of

  TJ-9 prevented these decreases in similar degree. However, decreases in serum

  and liver triglyceride concentration with the progression of liver injury

  were not attenuated after p.o. or i.p. administration of TJ-9. The activities

  of liver 5'-nucleotidase and glucose-6-phosphatase, marker enzymes of liver

  plasma and microsomal membranes, respectively, decreased during the

  progression of liver injury. A similar preventive effect on the decrease of

  both enzyme activities was found after p.o. or i.p. administration of TJ-9.

  These results indicate that the preventive effect on progression of

  GaIN-induced liver injury by oral or i.p. administration is approximately

  equal, and that the effect may be through improving the impaired liver

  protein synthesis and disrupted liver plasma and microsomal membranes in a

  similar degree.

 

<20>

Authors

  Piras G.  Makino M.  Baba M.

Institution

  Division of Human Retroviruses, Center for Chronic Viral Diseases, Faculty of

  Medicine, Kagoshima University, Japan.

Title

  Sho-saiko-to, a traditional Kampo medicine, enhances the

  anti-HIV-1 activity of lamivudine (3TC) in vitro.

Source

  Microbiology & Immunology.  41(10):835-9, 1997.

Abstract

  Sho-saiko-to (SST), a traditional Kampo medicine, has been

  examined for its inhibitory effect on human immunodeficiency virus type 1

  (HIV-1) replication in peripheral blood mononuclear cells (PBMCs). SST alone

  moderately inhibited HIV-1 replication at a concentration of 25 microg/ml.

  When SST was combined with zidovudine (AZT), lamivudine (3TC) or AZT plus

  3TC, SST enhanced the anti-HIV-1 activity of 3TC. In contrast, SST slightly

  enhanced the anti-HIV-1 activity of AZT plus 3TC but did not enhance the

  activity of AZT alone. These results suggest that the combination of SST and

  3TC has potential as a chemotherapeutic modality of HIV-1 infection.

 

<21>

Authors

  Kase Y.  Yuzurihara M.  Iizuka S.  Ishige A.  Komatsu Y.

Institution

  Central Research Laboratories, Tsumura & Co., Ibaraki, Japan.

Title

  The effects of hange-shashin-to on gastric function in comparison with

  sho-saiko-to.

Source

  Biological & Pharmaceutical Bulletin.  20(11):1155-9, 1997 Nov.

Abstract

  The effects of "Hange-shashin-to (TJ-14)" on gastric function were examined

  in comparison with "Sho-saiko-to (TJ-9)". Oral treatment

  with TJ-14 (125-500 mg/kg) caused dose-dependent suppression of

  ethanol-induced gastric injury, while it did not suppress gastric lesions

  induced by water-immersion stress. TJ-9 (125-500 mg/kg, p.o.) suppressed both

  water-immersion stress-induced gastric lesions and ethanol-induced gastric

  injury in a dose-dependent manner. Intraduodenal administration of TJ-14 even

  at 500 mg/kg did not affect gastric juice secretion, while TJ-9 at 125 to 500

  mg/kg dose-dependently suppressed gastric juice secretion. TJ-14 (125-500

  mg/kg, p.o.) accelerated gastric emptying in normal rats and improved the

  delayed gastric emptying induced by BaCl2 in a dose-dependent manner, whereas

  such effect was not noted with TJ-9. Oral treatment with TJ-14 at 500 mg/kg

  significantly suppressed apomorphine-induced vomiting, but it did not affect

  copper sulfate-induced vomiting. These results suggest that TJ-14 exhibits an

  anti-ulcer action (probably based on its ability to protect the gastric

  mucosa), improvement of gastric emptying and an anti-emetic action. TJ-9 also

  showed anti-ulcer effects, probably based on its ability to suppress gastric

  secretion and to protect the gastric mucosa. Thus, the present study

  demonstrated the effectiveness of TJ-14 and TJ-9 against gastric disease, and

  provided basic data which explain the differences in clinical application

  between these two kampo medicines.

 

<22>

Authors

  Huang Y.  Marumo K.  Murai M.

Institution

  Department of Urology, School of Medicine, Keio University, Tokyo, Japan.

Title

  Antitumor effects and pharmacological interaction of xiao-chai-hu-tang

  (sho-saiko-to) and interleukin 2 in murine renal cell

  carcinoma.

Source

  Keio Journal of Medicine.  46(3):132-7, 1997 Sep.

Abstract

  Conventional therapy for renal cell carcinoma using interleukin 2 (IL-2) has

  shown limited antitumor action. The purpose of our study was to investigate

  synergistic antitumor effects of IL-2 and Xiao-Chai-Hu-Tang (XCHT), and to

  elucidate the mechanisms of interaction between the two drugs against the

  murine renal cell carcinoma cell line, Renca, in vivo. The treatment was

  started 5 days after subcutaneous transplantation of Renca tumor. XCHT was

  given at a dose of 2.5 g/kg daily for 30 days orally. IL-2 was given at a

  dose of 10(4) U/mouse by subcutaneous injection every other day 8 times.

  Combination of XCHT and IL-2 inhibited growth of the tumor and prolonged

  survival significantly as compared with the untreated mice. Increased

  cellular infiltration was observed in tumor tissue and the lungs of mice

  treated with XCHT alone and by combination of XCHT and IL-2, but there were

  no histological changes in the liver and kidney. Elevation of serum IL-6 was

  observed in tumor-bearing mice, but IL-6 was significantly suppressed by

  administration of XCHT. The results obtained suggest that combination of XCHT

  and IL-2 induces enhanced immunological reaction in specific organs and

  tissues, and IL-6 may have a role in the synergistic effect of these two

  agents. It was concluded that combination of XCHT and IL-2 is useful in the

  treatment of patients with renal cell carcinoma.

 

<23>

Authors

  Terawaki K.  Nose M.  Ogihara Y.

Institution

  Department of Pharmacognosy and Plant Chemistry, Faculty of Pharmaceutical

  Sciences, Nagoya City University, Japan.

Title

  The effects of crude polysaccharide fractions of 4 kinds of kampo-hozai

  administered orally on nitric oxide production by murine peritoneal

  macrophages.

Source

  Biological & Pharmaceutical Bulletin.  20(7):809-11, 1997 Jul.

Abstract

  In order to characterize the pharmacological role of the crude polysaccharide

  fraction in kampo-hozai, we chose 4 kinds of kampo-hozai,

  Shosaiko-to, Daisaiko-to, Hachimi-jio-gan and Hochu-ekki-to,

  and studied the effects of their crude polysaccharide fractions on nitric

  oxide (NO) production by 3% thioglycollate-induced murine peritoneal

  macrophage. Oral administration of these fractions for 7 d augmented

  lipopolysaccharide (LPS, 0.1-10 micrograms/ml)-induced NO production by

  peritoneal macrophages. These results suggest the possibility that a crude

  polysaccharide fraction affect the macrophage function in most kampo-hozai.

 

<24>

Authors

  Li C.  Homma M.  Oka K.

Institution

  Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of

  Pharmacy and Life Science, Hachioji, Japan.

Title

  Chromatographic identification of phenolic compounds in human urine following

  oral administration of the herbal medicines Daisaiko-to and

  Shosaiko-to.

Source

  Journal of Chromatography. B, Biomedical Sciences & Applications.

  693(1):191-8, 1997 May 23.

Abstract

  Chemical identification of the compounds in human urine following

  administration of the traditional Chinese medicines, Daisaiko-to and

  Shosaiko-to (Dachaihu-tang and Xiaochaihu-tang in Chinese,

  respectively), was achieved by using a linear relationship between the

  logarithm of the capacity factor, log k', and that of the volume fraction of

  CH3CN, log X(s)(vol), in the aqueous mobile phase: -log k'=A+B log X(s)(vol).

  Comparison of the slope, B, and the intercept, A, between the urinary

  compound and its suspected authentic specimen gave satisfactory results in

  the chemical identification. We applied this method to the initial stage of

  pharmacokinetic studies on the herbal medicines and identified seven

  flavonoids and two anthraquinone derivatives in the urine specimens obtained

  after herbal administration.

 

<25>

Authors

  Matsumoto Y.  Kato M.  Tamada Y.  Mori H.  Ohashi M.

Institution

  Department of Dermatology, Nagoya University, School of Medicine, Japan.

Title

  Enhancement of interleukin-1 alpha mediated autocrine growth of cultured

  human keratinocytes by sho-saiko-to.

Source

  Japanese Journal of Pharmacology.  73(4):333-6, 1997 Apr.

Abstract

  We investigated the effects of Sho-saiko-to, the most

  commonly used herbal medicine in Japan, on the production of interleukin

  (IL)-1 alpha by cultured human epidermal keratinocytes. IL-1 alpha production

  was significantly promoted by treatment with 100 or 500 micrograms/ml

  Sho-saiko-to for 24 or 48 hr. Expression of IL-1 alpha

  receptors was the most markedly upregulated after treatment with 500

  micrograms/ml Sho-saiko-to for 24 hr and with 100 or 500

  micrograms/ml for 48 hr; these cells showed the characteristics of

  multilayered differentiated keratinocytes. The presence of an anti-IL-1 alpha

  antibody during the treatment with 500 micrograms/ml of

  Sho-saiko-to for 24 or 48 hr or with 100 micrograms/ml for

  48 hr significantly down-regulated the synthesis by the keratinocytes and

  induced damages in them. Keratinocytes treated with

  Sho-saiko-to might produce IL-1 alpha and express IL-1 alpha

  receptors. IL-1 alpha may regulate the proliferation and differentiation of

  keratinocytes after Sho-saiko-to treatment. These findings

  suggest that Sho-saiko-to enhances the autocrine growth

  mediated by IL-1 alpha.

 

<26>

Authors

  Yamashiki M.  Nishimura A.  Suzuki H.  Sakaguchi S.  Kosaka Y.

Institution

  Department of Laboratory Medicine, Mie University School of Medicine Tsu,

  Japan.

Title

  Effects of the Japanese herbal medicine "Sho-saiko-to"

  (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear

  cells of patients with chronic hepatitis C.

Source

  Hepatology.  25(6):1390-7, 1997 Jun.

Abstract

  "Sho-saiko-to" (TJ-9) consists of 7 herbal components. In

  Japan, it is widely prescribed to patients with chronic viral liver disease.

  TJ-9 is known to suppress liver cancer development and possess macrobiotic

  effects, but its mode of action is not fully understood. This study

  investigated the following: 1) cytokine production levels, mainly interleukin

  (IL)-10, in peripheral blood mononuclear cells of chronic active hepatitis B

  and C patients, and healthy volunteers; 2) effects of TJ-9 on these

  productions; and 3) effects of each of its herb components on cytokine

  production in cell fractions. Results showed that without stimulants, IL-10

  production in mononuclear cells of hepatitis B and C patients was

  significantly lower than that of healthy subjects (P < .01). IL-10 production

  induced by either phytohemagglutinin (PHA) or pokeweed mitogen (PWM) in

  mononuclear cells of hepatitis C patients were significantly lower than in

  patients with hepatitis B (P < .01) and healthy subjects (P < .05). IL-10

  production induced by anti-CD3 or lipopolysaccharide (LPS) was significantly

  lower than in healthy subjects (P < .05). The addition of TJ-9 to the

  cultures strongly induced IL-10, and this induction was mainly attributable

  to the effects of 2 components (scutellaria root and glycyrrhiza root) on the

  monocyte/macrophage fraction. The production of IL-4 and IL-5 in cultures

  with concanavalin A (conA) was significantly higher in patients with

  hepatitis C than in the healthy subjects (P < .01; P < .05), but the addition

  of TJ-9 suppressed these increases by 25% to 33% (P < .01). Therefore, TJ-9

  could adjust the decreased IL-10 production and the increased IL-4 and IL-5

  production of mononuclear cells from patients with hepatitis C. Moderate

  regulation of the cytokine production system in patients with hepatitis C by

  using TJ-9 may be useful in the prevention of disease progression.

 

<27>

Authors

  Ohtsu S.  Izumi S.  Iwanaga S.  Ohno N.  Yadomae T.

Institution

  Laboratory of Immunopharmacology of Microbial Products, School of Pharmacy,

  Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan.

Title

  Analysis of mitogenic substances in Bupleurum chinense by ESR spectroscopy.

Source

  Biological & Pharmaceutical Bulletin.  20(1):97-100, 1997 Jan.

Abstract

  The polyphenolic substance(s) in the hot water extract of Bupleurum chinense

  (PSF) showed strong mitogenic activity. In this paper, we analyzed PSF by

  using ESR spectroscopy, and found that i) PSF showed a strong ESR signal on g

  = 2.005 which was similar to the commercially available lignin; ii)

  Sho-saiko-to, which contains an extract of B. chinense, also

  showed similar signals on ESR; iii) Powdered B. chinense also showed similar

  signals on g = 2.005. Peroxidase activity, essential for producing

  polyphenolic substances, was detected in the cold water extract of B.

  chinense. In addition, the signal intensity of the ESR spectrum of B.

  chinense was increased after boiling. The data of the ESR spectra of the

  model reactions using lignin, arginine, proline and maltose also strongly

  suggested that a certain chemical modification proceeded during the hot water

  extraction to increase the percentage of the stable free radical. These facts

  strongly suggested that the mitogenic substance in B. chinense is a

  polyphenolic substance extracted by hot water, and the structure was modified

  during the extraction to increase the stable free radical components.

 
Copyright © 2002 Honso Pharmaceutical Co., Ltd. All rights reserved.
Honso® is a registered trademark of Honso Pharmaceutical Co., Ltd. For more information: info@honso.com